From Glioblastoma to Hepatitis C: It’s a Metabolism Thing

Slides:



Advertisements
Similar presentations
Value in Health Regional Issues
Advertisements

Clinical and pathologic effects of hepatocellular failure, which commonly results from conditions associated with acute or chronic necrosis of liver cells.
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Volume 22, Issue 5, Pages v-vi (May 2015)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini 
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma  Gia L. Tyson, Zhigang Duan, Jennifer R. Kramer,
Lymphotoxins: New Targets for Hepatocellular Carcinoma
SMAD About Hepatitis C Virus Cell Entry and Liver Disease
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 147, Issue 1, Pages (July 2014)
Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection  Adam.
Covering the Cover Gastroenterology
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Hepatocellular Carcinoma: Overcoming Challenges in Disease Management
Volume 153, Issue 4, Pages (October 2017)
Hepatitis B and C virus-related carcinogenesis
Change in number of HCV-infected patients in different stages in both scenarios. Change in number of HCV-infected patients in different stages in both.
Value in Health Regional Issues
Virological tools to diagnose and monitor hepatitis C virus infection
Chemical Proteomics of Host-Pathogen Interaction
Eric H. Raabe, Charles G. Eberhart  Cancer Cell 
Finding the Missing Code of RNA Recognition by PUF Proteins
The Promise of Advanced Imaging Techniques for the Detection of Hepatitis C Virus Antigens in the Infected Liver  Benno Wölk, MD, Darius Moradpour, MD 
Volume 69, Issue 2, Pages (August 2018)
Pioneering a Global Cure for Chronic Hepatitis C Virus Infection
Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH 
Chronic HCV infection and the clonality of intrahepatic T cells
A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study  M.-C. Tsai,
Volume 154, Issue 4, Pages (March 2018)
Cholesterol: An Achilles’ Heel for Glioblastoma?
Hepatitis C and Lymphoproliferative Disorders: From Mixed Cryoglobulinemia to Non- Hodgkin's Lymphoma  Lenna A. Martyak, Melina Yeganeh, Sammy Saab  Clinical.
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Michael Downes, Christopher Liddle  Cell Metabolism 
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 23, Issue 9, Pages (September 2016)
Treatment of hepatitis C
Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents  Andreas Kyvernitakis,
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Hepatitis C Virus Infection in the Older Patient
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Navigating the Maze of Hepatitis B Treatments
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Volume 142, Issue 6, Pages e3 (May 2012)
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Hepatitis B and C virus-related carcinogenesis
New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis  Pengcheng Ou, MD, Fangfang.
Immunopathogenesis of hepatitis C virus infection
Volume 21, Issue 11, Pages (November 2014)
Volume 21, Issue 8, Pages v-vi (August 2014)
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Volume 61, Issue 1, Pages S79-S90 (November 2014)
miR-122 – A key factor and therapeutic target in liver disease
HCV targeting of patients with cirrhosis
Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome  Allison J. Kasmari, MD, Amy Welch, MD, MSN,
Alan Bonder, MD, Nezam H. Afdhal, MD 
Ju Dong Yang, W. Ray Kim, Ritika Coelho, Teresa A. Mettler, Joanne T
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Liver Transplantation for Hepatocellular Carcinoma
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Volume 150, Issue 2, Pages (February 2016)
Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K
The metabolomic window into hepatobiliary disease
Volume 22, Issue 9, Pages (September 2015)
Volume 163, Issue 4, (November 2015)
Markov model of HCV–HCC disease process.
Reversion of disease manifestations after HCV eradication
Presentation transcript:

From Glioblastoma to Hepatitis C: It’s a Metabolism Thing Milka Kostic  Cell Chemical Biology  Volume 23, Issue 11, Pages 1315-1316 (November 2016) DOI: 10.1016/j.chembiol.2016.11.005 Copyright © 2016 Terms and Conditions

If you are a patient, this image is not something that you ever want to see—the evidence that you are suffering from glioblastoma (GBM), the most aggressive type of brain tumor, and one with a poor prognosis and withoutout a good treatment option. Villa et al. offer an interesting new option for GBM treatment by depriving GBM cells of cholesterol, a molecule they need to survive yet can’t make themselves. Source: Public domain via The Armed Forces Institute of Pathology (AFIP). Cell Chemical Biology 2016 23, 1315-1316DOI: (10.1016/j.chembiol.2016.11.005) Copyright © 2016 Terms and Conditions

Hepatitis C virus (HCV) is a very persistent pathogen that most commonly leads to chronic liver infection, which greatly damages the organ, causing cirrhosis. In some cases, HCV infection can lead to hepatocellular carcinoma, as shown in this liver specimen. Levy et al. expose nuclear receptors as important host factors that work for and against the virus, opening new therapeutic opportunities. Photograph by Ed Uthman, MD. Public domain. Cell Chemical Biology 2016 23, 1315-1316DOI: (10.1016/j.chembiol.2016.11.005) Copyright © 2016 Terms and Conditions